National Institutes of Health Director (NIH) praises psychedelics’ potential as therapeutic treatment…
Francis Collins, director of the National Institutes of Health (NIH) expressed positive remarks about the therapeutic potential of psychedelics such as psilocybin and MDMA.
“I think as we’ve learned more about how the brain works we began to realize that these are potential tools for research purposes and might be clinically beneficial,” Collins said. The NIH is the country’s main health agency responsible for public health research. As its director, Collins stands as the highest ranking health officer in the federal government.
Original Article (Yahoo News):
National Institutes of Health Director praises psychedelics’ potential as therapeutic treatment, touts progress in access to cannabis for research
Artwork Fair Use: Walter Henrique Pedron Moschen